Search Results - John T. Vetto
- Showing 1 - 19 results of 19
-
1
-
2
Identification of patients at risk of metastasis using a prognostic 31-gene expression profile in subpopulations of melanoma patients with favorable outcomes by standard criteria by Brian Gastman, Pedram Gerami, Sarah J. Kurley, Robert W. Cook, Sancy A. Leachman, John T. Vetto
Published 2018Artigo -
3
-
4
-
5
-
6
-
7
-
8
Adjuvant Therapy With Agonistic Antibodies to CD134 (OX40) Increases Local Control After Surgical or Radiation Therapy of Cancer in Mice by Michael J. Gough, Marka R. Crittenden, Maryclare Sarff, Puiyi Pang, Steven K. Seung, John T. Vetto, Hong‐Ming Hu, William L. Redmond, John Holland, Andrew D. Weinberg
Published 2010Artigo -
9
-
10
Southwest Oncology Group S0008: A Phase III Trial of High-Dose Interferon Alfa-2b Versus Cisplatin, Vinblastine, and Dacarbazine, Plus Interleukin-2 and Interferon in Patients With... by Lawrence E. Flaherty, Megan Othus, Michael B. Atkins, Ralph J. Tuthill, John A. Thompson, John T. Vetto, Frank G. Haluska, Alberto S. Pappo, Jeffrey A. Sosman, Bruce G. Redman, James J. Moon, Antoni Ribas, John M. Kirkwood, Vernon K. Sondak
Published 2014Artigo -
11
Guidance of Sentinel Lymph Node Biopsy Decisions In Patients With T1–T2 Melanoma Using Gene Expression Profiling by John T. Vetto, Eddy C. Hsueh, Brian Gastman, Larry D. Dillon, Federico A. Monzon, Robert W. Cook, Jennifer Keller, Xin Huang, Andrew M. Fleming, Preston W. Hewgley, Pedram Gerami, Sancy A. Leachman, Jeffrey D. Wayne, Adam C. Berger, Martin D. Fleming
Published 2019Artigo -
12
Phase I Trial of Preoperative Chemoradiation plus Sorafenib for High-Risk Extremity Soft Tissue Sarcomas with Dynamic Contrast-Enhanced MRI Correlates by Janelle Marie Meyer, Kelly S. Perlewitz, James B. Hayden, Yee-Cheen Doung, Arthur Hung, John T. Vetto, Rodney F. Pommier, Atiya Mansoor, Brooke Beckett, Alina Tudorica, Motomi Mori, Megan Holtorf, Aneela Afzal, William Woodward, Eve T. Rodler, Robin L. Jones, Wei Huang, Christopher W. Ryan
Published 2013Artigo -
13
Prognostic Value of Nevus-Associated Melanoma in Patients with Melanoma by Nazia Riaz, Anne Huibers, Stanley P. L. Leong, Mohammed Kashani‐Sabet, R. L. White, John T. Vetto, Schlomo Schneebaum, Cristina O’Donoghue, H. J. Howard, Eli Avisar, Jukes P. Namm, Heidi E. Kosiorek, Barbara A. Pockaj, Mark B. Faries, Giorgos C. Karakousis, Jonathan S. Zager, Roger Olofsson Bagge
Published 2025Artigo -
14
Performance of a prognostic 31-gene expression profile in an independent cohort of 523 cutaneous melanoma patients by Jonathan S. Zager, Brian Gastman, Sancy A. Leachman, René González, Martin D. Fleming, Laura K. Ferris, Jonhan Ho, Alexander R. Miller, Robert W. Cook, Kyle R. Covington, Kristen Meldi-Plasseraud, Brooke Middlebrook, Lewis H. Kaminester, Anthony Greisinger, Sarah Estrada, David M. Pariser, Lee D. Cranmer, Jane L. Messina, John T. Vetto, Jeffrey D. Wayne, Keith A. Delman, David H. Lawson, Pedram Gerami
Published 2018Artigo -
15
Integrating 31-Gene Expression Profiling With Clinicopathologic Features to Optimize Cutaneous Melanoma Sentinel Lymph Node Metastasis Prediction by Eric D. Whitman, Vadim P. Koshenkov, Brian Gastman, Deri Lewis, Eddy C. Hsueh, Ho Pak, Thomas P. Trezona, Robert S. Davidson, Michael McPhee, J. Michael Guenther, Paul Toomey, Franz O. Smith, Peter D. Beitsch, James M. Lewis, Andrew Ward, Shawn E. Young, Parth Shah, Ann P. Quick, Brian J. Martin, Olga Zolochevska, Kyle R. Covington, Federico A. Monzon, Matthew S. Goldberg, Robert W. Cook, Martin D. Fleming, David M. Hyams, John T. Vetto
Published 2021Artigo -
16
Factors Predictive of the Status of Sentinel Lymph Nodes in Melanoma Patients from a Large Multicenter Database by Richard L. White, Gregory D. Ayers, Virginia H. Stell, Shouluan Ding, Jeffrey E. Gershenwald, Jonathan C. Salo, Barbara A. Pockaj, Richard Essner, Mark B. Faries, Kim Charney, Eli Avisar, Axel Hauschild, Friederike Egberts, Bruce J. Averbook, Carlos A. Garberoglio, John T. Vetto, Merrick I. Ross, David Chu, Vijay Trisal, Harald J. Hoekstra, Eric D. Whitman, Harold J. Wanebo, Daniel L Debonis, Michael P. Vezeridis, Aaron Chevinsky, Mohammed Kashani‐Sabet, Yu Shyr, Lynne D. Berry, Zhiguo Zhao, Seng-Jaw Soong, Stanley P. L. Leong
Published 2011Artigo -
17
Chemoprevention agents for melanoma: A path forward into phase 3 clinical trials by Joanne Jeter, Tawnya L. Bowles, Clara Curiel‐Lewandrowski, Susan M. Swetter, Fabian V. Filipp, Zalfa Abdel‐Malek, Larisa J. Geskin, Jerry D. Brewer, Jack L. Arbiser, Jeffrey E. Gershenwald, Emily Y. Chu, John M. Kirkwood, Neil F. Box, Pauline Funchain, David E. Fisher, Kari Kendra, Ashfaq A. Marghoob, Suephy C. Chen, Michael E. Ming, Mark R. Albertini, John T. Vetto, Kim Margolin, Sherry Pagoto, Jennifer L. Hay, Douglas Grossman, Darrel L. Ellis, Mohammed Kashani‐Sabet, Aaron R. Mangold, Svetomir N. Markovic, Kelly C. Nelson, Jennifer G. Powers, June K. Robinson, Debjani Sahni, Aleksandar Sekulić, Vernon K. Sondak, Maria L. Wei, Jonathan S. Zager, Robert P. Dellavalle, John A. Thompson, Martin A. Weinstock, Sancy A. Leachman, Pamela B. Cassidy
Published 2018Revisão -
18
Active surveillance of patients who have sentinel node positive melanoma: An international, multi‐institution evaluation of adoption and early outcomes after the Multicenter Select... by Kristy K. Broman, Tasha M. Hughes, Lesly A. Dossett, James Sun, Д. А. Кириченко, Michael J. Carr, Avinash Sharma, Edmund K. Bartlett, Amanda A. G. Nijhuis, John F. Thompson, Tina J. Hieken, Lisa A. Kottschade, Jennifer Downs, David Gyorki, Emma H. A. Stahlie, Alexander C.J. van Akkooi, David W. Ollila, Jill S. Frank, Yun Song, Giorgos C. Karakousis, Marc Moncrieff, Jenny Nobes, John T. Vetto, Dale Han, Jeffrey M. Farma, Jeremiah L. Deneve, Martin D. Fleming, Matthew Perez, Michael Lowe, Roger Olofsson Bagge, Jan Mattsson, Ann Y. Lee, Russell S. Berman, Harvey Chai, Hidde M. Kroon, J Teras, Roland M. Teras, Norma E. Farrow, Georgia M. Beasley, Jane Yuet Ching Hui, Lukas B. Been, Schelto Kruijff, Youngchul Kim, Syeda Mahrukh Hussnain Naqvi, Amod A. Sarnaik, Vernon K. Sondak, Jonathan S. Zager
Published 2021Artigo -
19
Skin Cancer Screening: Recommendations for Data-Driven Screening Guidelines and a review of the US Preventive Services Task Force Controversy by Mariah Johnson, Sancy A. Leachman, Lisa G. Aspinwall, Lee D. Cranmer, Clara Curiel‐Lewandrowski, Vernon K. Sondak, Clara E. Stemwedel, Susan M. Swetter, John T. Vetto, Tawnya L. Bowles, Robert P. Dellavalle, Larisa J. Geskin, Douglas Grossman, Kenneth F. Grossmann, Jason E. Hawkes, Joanne Jeter, Caroline C. Kim, John M. Kirkwood, Aaron R. Mangold, Frank L. Meyskens, Michael E. Ming, Kelly C. Nelson, Michael W. Piepkorn, Brian P. Pollack, June K. Robinson, Arthur J. Sober, Shannon C. Trotter, Suraj Venna, Sanjiv S. Agarwala, Rhoda M. Alani, Bruce J. Averbook, Anna Bar, Mirna Becevic, Neil F. Box, William E. Carson, Pamela B. Cassidy, Suephy C. Chen, Emily Y. Chu, Darrel L. Ellis, Laura K. Ferris, David E. Fisher, Kari Kendra, David H. Lawson, Philip D. Leming, Kim Margolin, Svetomir Markovic, Mary C. Martini, Debbie Miller, Debjani Sahni, William H. Sharfman, Jennifer Stein, Alexander Stratigos, Ahmad A. Tarhini, Matthew H. Taylor, Oliver J. Wisco, Michael K. Wong
Published 2017Revisão
Search Tools:
Related Subjects
Medicine
Cancer
Internal medicine
Cancer research
Oncology
Biology
Melanoma
Breast cancer
Pathology
Sentinel lymph node
Confidence interval
Immunology
Surgery
Cohort
Hazard ratio
Metastasis
Biopsy
Chemotherapy
Gastroenterology
Genetics
Immunotherapy
Lymph node
Paleontology
Proportional hazards model
Stage (stratigraphy)
Adjuvant therapy
Biochemistry
Biotechnology
Computer science
Cytotoxic T cell